These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 404456)

  • 1. [Cross-resistance of tubercle bacilli. (A review II) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Feb; 52(2):47-9. PubMed ID: 404456
    [No Abstract]   [Full Text] [Related]  

  • 2. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 6. [The mutual cross-resistance of aminoglucoside and polypeptide antibiotics on tubercle bacilli (author's transl)].
    Inagake H
    Kekkaku; 1980 Jun; 55(6):281-8. PubMed ID: 6774157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cross-resistance of tubercle bacilli (a review). (I) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Jan; 52(1):17-20. PubMed ID: 402497
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1979 Feb; 54(2):89-92. PubMed ID: 108446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
    Fukuhara Y
    Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical significance of the critical drug concentration of rifampicin. Report 1. Studies on the MIC of rifampicin to tubercle bacilli isolated from the rifampicin untreated patients using 1% Ogawa medium (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):1-5. PubMed ID: 815708
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)].
    Toyoara M
    Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)].
    Xiao XL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Aug; 4(4):224-5. PubMed ID: 6804194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on thiacetazone resistance of tubercle bacilli. 3. Cross resistance between thiacetazone and ethionamide].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 Apr; 46(4):89-92. PubMed ID: 4102105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Peracetic acid as a disinfectant in the fight against tuberculosis--experimental data-- (author's transl)].
    Sachse H
    Z Erkr Atmungsorgane; 1976; 144(1):33-8. PubMed ID: 823717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on resistance of tubercle bacilli to reserve drugs. II. Resistance to viomycin and kanamycin in experimenta tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1966 Oct; 34(10):903-6. PubMed ID: 4292274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on thiacetazone resistance of tubercle bacilli. I. Thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 May; 46(3):65-70. PubMed ID: 4101569
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug activity of bleomycin against tubercle bacilli isolated from pulmonary tuberculous in-patients (author's transl)].
    Endo K
    Jpn J Antibiot; 1973 Dec; 26(6):501-3. PubMed ID: 4131340
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on cross-resistance between isoniazid, isoxyl, teebazone, ethionamide and ethambutol of tubercle bacilli from patients never treated with those drugs except with isoniazid.
    Tan TH; The KS; Yang SY; Tan LS; Ko HL; Tjie HB; Chatim A
    Paediatr Indones; 1966; 6(1):32-8. PubMed ID: 4959380
    [No Abstract]   [Full Text] [Related]  

  • 19. Tubercle bacilli resistance to cycloserine.
    Zierski M; Rózewska M; Woźniak S
    Scand J Respir Dis Suppl; 1970; 71():291-5. PubMed ID: 4989519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pattern of resistance development of Mycobacterium tuberculosis (H37Rv) to minocycline (author's transl)].
    Tsukamura M; Mizuno S; Murata H
    Kekkaku; 1981 Oct; 56(10):459-63. PubMed ID: 6798294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.